Beyond the peptide category
NAD+
A nucleotide coenzyme involved in cellular metabolism. NAD+ is not a peptide.
Non-peptide compounds · Educational information only · No medical advice
← Peptide library · Start Here
Non-peptide coenzymeAlso discussed as: Nicotinamide adenine dinucleotide
What it is and how it works
NAD+ and its reduced form, NADH, participate in cellular oxidation-reduction reactions. Its normal role in cells explains scientific interest, but does not establish that administering a commercial NAD+ product improves energy or reverses aging.
Source for this context →A closer look at the cited evidence
Biology + safety context
This label describes the selected source below. It is not a complete ranking of the literature, a safety score, or an approval status.
- Study or assessment
- FDA — ingredients suitable for sterile compounding
- Design
- Regulatory safety communication, not a wellness effectiveness trial.
- Who or what was studied
- Reports associated with compounded NAD+ injectable products.
- What was observed
- FDA received reports of severe chills, shaking, vomiting, and fatigue, with some requiring medical treatment.
- Limits of interpretation
- Reports do not determine every event’s cause or establish effectiveness. Oral precursors and intravenous NAD+ are distinct products.
Regulatory context
A normal cellular role does not confer FDA approval for an anti-aging infusion. A compounded product is not FDA approved.
Safety considerations
Sterile-product quality is a separate safety question from a molecule’s biological function. Research-use or supplement-grade material cannot establish suitability for an injectable drug.
What remains uncertain
Evidence about a precursor supplement cannot automatically answer questions about NAD+ infusions. A useful study would need to specify the product, route, population, clinical outcome, and adverse events.
